EDN1 and idiopathic pulmonary fibrosis: Endothelin-1 blockade has been shown to block TGF-β-induced myofibroblastic differentiation in cultured lung fibroblasts [38], and an ET-1 antagonist has been shown to delay death in a cohort of idiopathic pulmonary fibrosis patients [39].